Tag Archives: disease

MGH researchers studying early onset celiac disease

A collaborative group of researchers has identified substantial microbial changes in the intestines of at-risk infants before disease onset in a new, long-term, prospective approach to the development of celiac disease. Using advanced genomic sequencing techniques, MassGeneral Hospital for Children (MGHfC) researchers, along with colleagues from institutions in Italy and the University of Maryland, College… Read More »

FDA Approves Vaxneuvance (Pneumococcal 15-valent Conjugate Vaccine) for the Prevention of Invasive Pneumococcal Disease in Adults

FDA Approves Vaxneuvance (Pneumococcal 15-valent Conjugate Vaccine) for the Prevention of Invasive Pneumococcal Disease in Adults KENILWORTH, N.J.–(BUSINESS WIRE)– (NYSE: MRK), known as MSD outside the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) approved Vaxneuvance (Pneumococcal 15-valent Conjugate Vaccine) (pronounced VAKS-noo-vans) for active immunization for the prevention of invasive… Read More »

A schizophrenia expert discovers an even ‘weirder’ disease: His own

Breadcrumb Trail Links News Health Canada ‘One treatment for my disease makes it more likely that I will become a gambler’ Author of the article: Joseph Brean E. Fuller Torrey is a research psychiatrist and expert on schizophrenia who calls Parkinson’s disease, from which he personally suffers, the “weirdest disease” known to medicine. Photo by… Read More »

Aduhelm and Alzheimer’s Disease: A Potential Medicare Budget-Buster Puts A Blazing Light on Health Care Costs and Innovation

The FDA’s approval of the first therapy to treat Alzheimer’s Disease in over twenty years brought attention to a not-yet-convened debate of U.S. health care costs and spending, innovation, and return-on-the-investment (as well as “for whom” do the returns accrue). In my latest post for Medecision, I explore different angles on the Aduhelm and Alzheimer’s… Read More »